東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Obesity and cancer

Kumar, Shashank.

FindBook

Google Book

Amazon

博客來

Obesity and cancer

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Obesity and cancer/ edited by Shashank Kumar, Sanjay Gupta.
其他作者:	Kumar, Shashank.
出版者:	Singapore :Springer Singapore : : 2021.,
面頁冊數:	ix, 361 p. :ill. (some col.), digital ;24 cm.
內容註:	Chapter 1. Obesity induced chronic low-level inflammation and cancers -- Chapter 2. Adipose tissue produced estrogen as risk factor for cancers -- Chapter 3. Insulin and Insulin-like growth factor-1 associated cancers -- Chapter 4. Adipokines play important role in cell proliferation and antiproliferation -- Chapter 5. mTOR and AMP-activated protein kinase in obesity and cancer -- Chapter 6. Immune response and oxidative stress in obesity induced cancer -- Chapter 7. Role of gene polymorphism in obesity and cancer -- Chapter 8. Therapeutic role of green tea in obesity and cancer -- Chapter 9. Effect of dietary phytochemicals in obesity and cancer -- Chapter 10. Resveratrol as anti-obesity and anticancer agent -- Chapter 11. EGCG as anti-obesity and anticancer agent -- Chapter 12. miRNAs as therapeutic target in obesity and cancer -- Chapter 13. In silico updates on lead identification for obesity and cancer -- Chapter 14. In vivo models for obesity and obesity related carcinogenesis -- Chapter 15. Estrogen signaling based current and potential therapies against obesity and related diseases -- Chapter 16. Autophagy at the crossroad of obesity mediated cancer progression.
Contained By:	Springer Nature eBook
標題:	Obesity. -
電子資源:	https://doi.org/10.1007/978-981-16-1846-8
ISBN:	9789811618468

Obesity and cancer
Obesity and cancer[electronic resource] /edited by Shashank Kumar, Sanjay Gupta. - Singapore :Springer Singapore :2021. - ix, 361 p. :ill. (some col.), digital ;24 cm.

Chapter 1. Obesity induced chronic low-level inflammation and cancers -- Chapter 2. Adipose tissue produced estrogen as risk factor for cancers -- Chapter 3. Insulin and Insulin-like growth factor-1 associated cancers -- Chapter 4. Adipokines play important role in cell proliferation and antiproliferation -- Chapter 5. mTOR and AMP-activated protein kinase in obesity and cancer -- Chapter 6. Immune response and oxidative stress in obesity induced cancer -- Chapter 7. Role of gene polymorphism in obesity and cancer -- Chapter 8. Therapeutic role of green tea in obesity and cancer -- Chapter 9. Effect of dietary phytochemicals in obesity and cancer -- Chapter 10. Resveratrol as anti-obesity and anticancer agent -- Chapter 11. EGCG as anti-obesity and anticancer agent -- Chapter 12. miRNAs as therapeutic target in obesity and cancer -- Chapter 13. In silico updates on lead identification for obesity and cancer -- Chapter 14. In vivo models for obesity and obesity related carcinogenesis -- Chapter 15. Estrogen signaling based current and potential therapies against obesity and related diseases -- Chapter 16. Autophagy at the crossroad of obesity mediated cancer progression.

This book highlights the concordance between signaling pathways that are involved in obesity and cancer cross-talks. It describes the role of cytokines, chemokines, growth factors, insulin, and adipokines in the development of obesity-associated cancers. The book reviews the role of inflammatory signaling pathways such as estrogen-mediated signaling, mTOR and AMP-activated protein kinase pathway and the involvement of adaptive and innate immunity, oxidative stress, gene polymorphism, dietary phytochemicals, and miRNAs in obesity and cancer. In addition, it covers the latest research on the drugs and natural therapeutic agents that target obesity-induced cancers and discusses various in vivo models for studying obesity and obesity-associated cancer. Lastly, it analyses the role of genetic polymorphisms in the obesity-related genes that influence cancer development. The book is a useful resource for researchers in the field of cancer, pharmacology, food chemistry, and clinical biochemistry.

ISBN: 9789811618468

Standard No.: 10.1007/978-981-16-1846-8doiSubjects--Topical Terms:

525736
Obesity.

LC Class. No.: RC628 / .O24 2021

Dewey Class. No.: 616.398

Obesity and cancer
LDR:03175nmm a2200325 a 4500 001 2241957
003 DE-He213
005 20210718204932.0
006 m d
007 cr nn 008maaau
008 211207s2021 si s 0 eng d
020 $a 9789811618468 $q (electronic bk.)
020 $a 9789811618451 $q (paper)
024 7 $a 10.1007/978-981-16-1846-8 $2 doi
035 $a 978-981-16-1846-8
040 $a GP $c GP
041 0 $a eng
050 4 $a RC628 $b .O24 2021
072 7 $a MJCL $2 bicssc
072 7 $a MED062000 $2 bisacsh
072 7 $a MJCL $2 thema
082 0 4 $a 616.398 $2 23
090 $a RC628 $b .O12 2021
245 0 0 $a Obesity and cancer $h [electronic resource] / $c edited by Shashank Kumar, Sanjay Gupta.
260 $a Singapore : $b Springer Singapore : $b Imprint: Springer, $c 2021.
300 $a ix, 361 p. : $b ill. (some col.), digital ; $c 24 cm.
505 0 $a Chapter 1. Obesity induced chronic low-level inflammation and cancers -- Chapter 2. Adipose tissue produced estrogen as risk factor for cancers -- Chapter 3. Insulin and Insulin-like growth factor-1 associated cancers -- Chapter 4. Adipokines play important role in cell proliferation and antiproliferation -- Chapter 5. mTOR and AMP-activated protein kinase in obesity and cancer -- Chapter 6. Immune response and oxidative stress in obesity induced cancer -- Chapter 7. Role of gene polymorphism in obesity and cancer -- Chapter 8. Therapeutic role of green tea in obesity and cancer -- Chapter 9. Effect of dietary phytochemicals in obesity and cancer -- Chapter 10. Resveratrol as anti-obesity and anticancer agent -- Chapter 11. EGCG as anti-obesity and anticancer agent -- Chapter 12. miRNAs as therapeutic target in obesity and cancer -- Chapter 13. In silico updates on lead identification for obesity and cancer -- Chapter 14. In vivo models for obesity and obesity related carcinogenesis -- Chapter 15. Estrogen signaling based current and potential therapies against obesity and related diseases -- Chapter 16. Autophagy at the crossroad of obesity mediated cancer progression.
520 $a This book highlights the concordance between signaling pathways that are involved in obesity and cancer cross-talks. It describes the role of cytokines, chemokines, growth factors, insulin, and adipokines in the development of obesity-associated cancers. The book reviews the role of inflammatory signaling pathways such as estrogen-mediated signaling, mTOR and AMP-activated protein kinase pathway and the involvement of adaptive and innate immunity, oxidative stress, gene polymorphism, dietary phytochemicals, and miRNAs in obesity and cancer. In addition, it covers the latest research on the drugs and natural therapeutic agents that target obesity-induced cancers and discusses various in vivo models for studying obesity and obesity-associated cancer. Lastly, it analyses the role of genetic polymorphisms in the obesity-related genes that influence cancer development. The book is a useful resource for researchers in the field of cancer, pharmacology, food chemistry, and clinical biochemistry.
650 0 $a Obesity. $3 525736
650 0 $a Cancer $x Etiology. $3 1005423
650 0 $a Comorbidity. $3 838466
650 1 4 $a Cancer Research. $3 891172
650 2 4 $a Medicine/Public Health, general. $3 891342
650 2 4 $a Immunology. $3 611031
650 2 4 $a Bioinformatics. $3 553671
700 1 $a Kumar, Shashank. $3 3411685
700 1 $a Gupta, Sanjay. $3 2056175
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer Nature eBook
856 4 0 $u https://doi.org/10.1007/978-981-16-1846-8
950 $a Biomedical and Life Sciences (SpringerNature-11642)